Cybin (CYBN) announced that it has launched an at-the-market equity program to allow Cybin to issue and sell up to $100M of common shares in the capital of the company from treasury to the public, from time to time, through Cantor Fitzgerald and Co. and Cantor Fitzgerald Canada Corporation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYBN:
- Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq in Early January
- Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
- Jefferies sees potential tailwind forming for psychedelics from marijuana shift
- Cybin to transfer U.S. stock exchange listing to Nasdaq
- Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial